Atom Investors’s Enfusion, Inc. ENFN Stock Holding History

Atom Investors’s Portfolio ENFN Stock Details ENFN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-36,100	Closed	-$403K	–	808
2025 Q1	$403K	Sell	36,100 -173,169	-83%	-$1.91M	0.05%	326
2024 Q4	$2.16M	Sell	209,269 -43,709	-17%	-$422K	0.27%	119
2024 Q3	$2.4M	Buy	252,978 +5,858	+2%	+$50.5K	0.25%	134
2024 Q2	$2.11M	Buy	247,120 +53,213	+27%	+$487K	0.21%	155
2024 Q1	$1.79M	Buy	193,907 +131,937	+213%	+$1.16M	0.22%	156
2023 Q4	$601K	Buy	61,970 +18,747	+43%	+$175K	0.11%	249
2023 Q3	$388K	Buy	+43,223	New	+$410K	0.09%	274
2023 Q1	–	Sell	-35,707	Closed	-$345K	–	330
2022 Q4	$345K	Sell	35,707 -31,572	-47%	-$356K	0.17%	119
2022 Q3	$830K	Sell	67,279 -7,243	-10%	-$88.4K	0.29%	111
2022 Q2	$761K	Buy	+74,522	New	+$823K	0.33%	91
2022 Q1	–	Sell	-26,136	Closed	-$547K	–	343
2021 Q4	$547K	Buy	+26,136	New	+$528K	0.09%	155

Other funds holding ENFN

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Atom Investors's ENFN Position: Q2 2025 in Review

Atom Investors sold out of Enfusion, Inc. (ENFN) in Q2 2025, closing a stake of 36,100 shares — an estimated $403K sold.

Atom Investors first reported a position in ENFN in Q4 2021 and held it in 11 quarters. The position peaked at $2.4M in Q3 2024. 2 funds tracked by Wall St. Rank hold ENFN as of Q2 2025.

Atom Investors reported no remaining Enfusion, Inc. position as of Q2 2025 after selling out during the quarter.
Atom Investors sold 36,100 Enfusion, Inc. shares in Q2 2025, an estimated $403K.
Atom Investors first reported a position in Enfusion, Inc. in Q4 2021 and held it in 11 quarters.
Atom Investors's Enfusion, Inc. position peaked at $2.4M in Q3 2024.
2 funds tracked by Wall St. Rank held Enfusion, Inc. as of Q2 2025.

Based on Atom Investors's 13F filing for Q2 2025, filed 14 Aug 2025.